The mechanisms included nitric oxide and superoxide radical scavenging activities and COX1 and COX2 enzyme inhibitory activities for anti-inflammatory activity, growth inhibition and cytotoxicity against MCF7, HePG2 and AN3CA human carcinoma cell lines and glutathionase-S-transferase inhibitory activity for anticancer related activity and HMG-CoA reductase, lipase, cholesterol esterase and cholesterol micellization inhibitory activities for antilipidemic activity. The gene discussed is HMGCR; the disease is carcinoma.